You just read:

Amsterdam Molecular Therapeutics Ontvangt Nieuwe Opinie over Goedkeurigsprocedure van Glybera®

News provided by

Amsterdam Molecular Therapeutics (AMT) B.V

Apr 23, 2012, 05:29 ET